Surgical Innovations Group plc (SUN.L)
- Previous Close
0.5000 - Open
0.4800 - Bid 0.4000 x --
- Ask 0.6000 x --
- Day's Range
0.4200 - 0.4800 - 52 Week Range
0.3650 - 2.3500 - Volume
1,162,877 - Avg. Volume
1,467,102 - Market Cap (intraday)
4.664M - Beta (5Y Monthly) 0.32
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Apr 18, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.00
Surgical Innovations Group plc, together with its subsidiaries, designs, develops, manufactures, and sells devices for use in minimally invasive surgery and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company offers YelloPort Elite and YelloPort +plus port access systems; PretzelFlex, a surgical retracting system; FastClamp, an endoscopic clamping system; LogiCut, a disposable laparoscopic insert; Logic, a reusable laparoscopic instrument; and LogiFlex, an articulating dissector and retractor. It also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and build of instruments. In addition, the company distributes medical products; and designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was incorporated in 1988 and is based in Leeds, the United Kingdom.
www.sigroupplc.comRecent News: SUN.L
Performance Overview: SUN.L
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SUN.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SUN.L
Valuation Measures
Market Cap
4.66M
Enterprise Value
5.11M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.39
Price/Book (mrq)
0.44
Enterprise Value/Revenue
0.43
Enterprise Value/EBITDA
31.76
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.24%
Return on Assets (ttm)
-2.49%
Return on Equity (ttm)
-4.75%
Revenue (ttm)
12.01M
Net Income Avi to Common (ttm)
-509k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.21M
Total Debt/Equity (mrq)
15.85%
Levered Free Cash Flow (ttm)
-313k
Research Analysis: SUN.L
Company Insights: SUN.L
SUN.L does not have Company Insights